We are live on ! Find out more
VTAE

VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE

Delisted

VTAE was delisted on the 24th of October, 2016.

Back to rankings

Fund managers haven’t disclosed any holdings of VTAE yet.

VTAE Hedge Fund Activity: Q4 2016 in Review

0 of the 4,001 institutional investors tracked by Wall St. Rank reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) for Q4 2016, worth a combined $0 — down 100% from $504M a quarter earlier.

Sellers outnumbered buyers: 98 funds closed out of VTAE and 0 opened new positions — a net loss of 98 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Alpine Associates Management, exiting entirely with an estimated $37.5M sold.

  • 0 institutional investors held VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) as of Q4 2016, down from 98 in Q3 2016.
  • Funds reported $0 of VITAE PHARMACEUTICALS INC COMMON STOCK stock for Q4 2016, down 100% quarter-over-quarter.
  • 0 funds opened new VITAE PHARMACEUTICALS INC COMMON STOCK positions in Q4 2016 and 98 closed out, a net change of -98 holders.
  • The largest VITAE PHARMACEUTICALS INC COMMON STOCK seller in Q4 2016 was Alpine Associates Management, an estimated $37.5M sold.

Based on aggregated 13F filings for Q4 2016.